• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Let-7家族微小RNA调控急性髓系白血病细胞中尿激酶受体的表达。

Let-7 Family microRNAs Regulate the Expression of the Urokinase-Receptor in Acute Myeloid Leukemia Cells.

作者信息

Li Santi Anna, Alfieri Mariaevelina, Meo Luigia, Ragno Pia

机构信息

Department of Chemistry and Biology, University of Salerno, 84084 Fisciano (Salerno), Italy.

Clinical Pathology, Pausilipon Hospital, A.O.R.N Santobono-Pausilipon, 80129 Naples, Italy.

出版信息

Cells. 2025 Apr 22;14(9):623. doi: 10.3390/cells14090623.

DOI:10.3390/cells14090623
PMID:40358147
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12071396/
Abstract

The urokinase-receptor (uPAR) exerts multiple functions supporting most cancer hallmarks. Increased uPAR expression is associated with an unfavorable prognosis in several cancer types, including hematologic malignancies. We previously reported that three oncosuppressor microRNAs (miRNAs) can target the 3'untranslated region (3'UTR) of the uPAR mRNA and that uPAR mRNA is a competitive endogenous RNA (ceRNA) able to recruit oncosuppressor miRs, thus impairing their activity. We now show that uPAR mRNA can also be targeted by oncosuppressor members of the let-7 miRNA family in acute myeloid leukemia (AML) cell lines. Indeed, let-7a, let7d and let-7g directly target the 3'UTR of uPAR mRNA, thus down-regulating uPAR expression. These let-7 miRNAs are expressed in KG1 and U937 AML cells; their levels are high in KG1 cells, which express low uPAR levels, and low in the U937 cell line, expressing high levels of uPAR. Overexpression of these miRNAs down-regulates uPAR expression and impairs the adhesion to fibronectin and migration of U937 cells, without affecting their proliferation. Accordingly, the overexpression of specific inhibitors targeting these let-7 miRNAs efficiently increases uPAR expression in KG1 cells. These results indicate that selected let-7 miRNAs regulate uPAR expression and impair the adhesion and migration of AML cells.

摘要

尿激酶受体(uPAR)发挥多种功能,支持大多数癌症特征。uPAR表达增加与包括血液系统恶性肿瘤在内的多种癌症类型的不良预后相关。我们之前报道过,三种抑癌微小RNA(miRNA)可靶向uPAR mRNA的3'非翻译区(3'UTR),且uPAR mRNA是一种竞争性内源性RNA(ceRNA),能够募集抑癌miR,从而损害其活性。我们现在发现,在急性髓系白血病(AML)细胞系中,uPAR mRNA也可被let-7 miRNA家族的抑癌成员靶向。事实上,let-7a、let-7d和let-7g直接靶向uPAR mRNA的3'UTR,从而下调uPAR表达。这些let-7 miRNA在KG1和U937 AML细胞中表达;它们在表达低水平uPAR的KG1细胞中水平较高,而在表达高水平uPAR的U937细胞系中水平较低。这些miRNA的过表达下调了uPAR表达,并损害了U937细胞对纤连蛋白的黏附及迁移能力,但不影响其增殖。相应地,靶向这些let-7 miRNA的特异性抑制剂的过表达有效增加了KG1细胞中的uPAR表达。这些结果表明,特定的let-7 miRNA调节uPAR表达,并损害AML细胞的黏附与迁移能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fec9/12071396/33025892343a/cells-14-00623-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fec9/12071396/89fe541ff804/cells-14-00623-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fec9/12071396/aec3c6b7b876/cells-14-00623-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fec9/12071396/83f4225b573a/cells-14-00623-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fec9/12071396/0c84eba35995/cells-14-00623-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fec9/12071396/1a13fe5915a2/cells-14-00623-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fec9/12071396/33025892343a/cells-14-00623-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fec9/12071396/89fe541ff804/cells-14-00623-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fec9/12071396/aec3c6b7b876/cells-14-00623-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fec9/12071396/83f4225b573a/cells-14-00623-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fec9/12071396/0c84eba35995/cells-14-00623-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fec9/12071396/1a13fe5915a2/cells-14-00623-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fec9/12071396/33025892343a/cells-14-00623-g006.jpg

相似文献

1
Let-7 Family microRNAs Regulate the Expression of the Urokinase-Receptor in Acute Myeloid Leukemia Cells.Let-7家族微小RNA调控急性髓系白血病细胞中尿激酶受体的表达。
Cells. 2025 Apr 22;14(9):623. doi: 10.3390/cells14090623.
2
Urokinase receptor and CXCR4 are regulated by common microRNAs in leukaemia cells.尿激酶受体和CXCR4在白血病细胞中受共同的微小RNA调控。
J Cell Mol Med. 2015 Sep;19(9):2262-72. doi: 10.1111/jcmm.12617. Epub 2015 Jun 16.
3
A novel oncogenic role for urokinase receptor in leukemia cells: molecular sponge for oncosuppressor microRNAs.尿激酶受体在白血病细胞中的一种新的致癌作用:肿瘤抑制性微小RNA的分子海绵
Oncotarget. 2018 Jun 12;9(45):27823-27834. doi: 10.18632/oncotarget.25597.
4
Identification of uPAR Variants Acting as ceRNAs in Leukaemia Cells.白血病细胞中作为竞争性内源RNA发挥作用的尿激酶型纤溶酶原激活物受体(uPAR)变体的鉴定
Cancers (Basel). 2022 Apr 14;14(8):1980. doi: 10.3390/cancers14081980.
5
Regulation of urokinase receptor expression by p53: novel role in stabilization of uPAR mRNA.p53对尿激酶受体表达的调控:在稳定尿激酶型纤溶酶原激活剂受体(uPAR)mRNA中的新作用。
Mol Cell Biol. 2007 Aug;27(16):5607-18. doi: 10.1128/MCB.00080-07. Epub 2007 Jun 4.
6
MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7.微小 RNA let-7a 通过下调 C-C 趋化因子受体 7 抑制乳腺癌细胞迁移和侵袭。
Breast Cancer Res. 2012 Jan 18;14(1):R14. doi: 10.1186/bcr3098.
7
Let-7a inhibits migration, invasion and epithelial-mesenchymal transition by targeting HMGA2 in nasopharyngeal carcinoma.Let-7a通过靶向鼻咽癌中的HMGA2抑制迁移、侵袭和上皮-间质转化。
J Transl Med. 2015 Mar 31;13:105. doi: 10.1186/s12967-015-0462-8.
8
Tristetraprolin inhibits the growth of human glioma cells through downregulation of urokinase plasminogen activator/urokinase plasminogen activator receptor mRNAs.锌指蛋白683通过下调尿激酶型纤溶酶原激活剂/尿激酶型纤溶酶原激活剂受体mRNA来抑制人胶质瘤细胞的生长。
Mol Cells. 2015;38(2):156-62. doi: 10.14348/molcells.2015.2259. Epub 2014 Dec 30.
9
miR‑1271‑5p inhibits cell proliferation and induces apoptosis in acute myeloid leukemia by targeting ZIC2.miR-1271-5p 通过靶向 ZIC2 抑制急性髓系白血病细胞增殖并诱导细胞凋亡。
Mol Med Rep. 2019 Jan;19(1):508-514. doi: 10.3892/mmr.2018.9680. Epub 2018 Nov 21.
10
Single amino acid substitutions in the chemotactic sequence of urokinase receptor modulate cell migration and invasion.尿激酶受体趋化序列中的单个氨基酸取代可调节细胞迁移和侵袭。
PLoS One. 2012;7(9):e44806. doi: 10.1371/journal.pone.0044806. Epub 2012 Sep 25.

本文引用的文献

1
Insight into microRNAs' involvement in hematopoiesis: current standing point of findings.探讨 microRNAs 参与造血过程的研究现状
Stem Cell Res Ther. 2023 Oct 4;14(1):282. doi: 10.1186/s13287-023-03504-3.
2
Clinical Significance of microRNAs in Hematologic Malignancies and Hematopoietic Stem Cell Transplantation.微小RNA在血液系统恶性肿瘤和造血干细胞移植中的临床意义
Cancers (Basel). 2023 May 8;15(9):2658. doi: 10.3390/cancers15092658.
3
Posttranscriptional Regulation of the Plasminogen Activation System by Non-Coding RNA in Cancer.
非编码 RNA 对癌症纤溶酶原激活系统的转录后调控
Int J Mol Sci. 2023 Jan 4;24(2):962. doi: 10.3390/ijms24020962.
4
Modulation of Cellular Function by the Urokinase Receptor Signalling: A Mechanistic View.尿激酶受体信号传导对细胞功能的调节:一种机制性观点
Front Cell Dev Biol. 2022 Apr 8;10:818616. doi: 10.3389/fcell.2022.818616. eCollection 2022.
5
Identification of uPAR Variants Acting as ceRNAs in Leukaemia Cells.白血病细胞中作为竞争性内源RNA发挥作用的尿激酶型纤溶酶原激活物受体(uPAR)变体的鉴定
Cancers (Basel). 2022 Apr 14;14(8):1980. doi: 10.3390/cancers14081980.
6
Circ_KCNQ5 participates in the progression of childhood acute myeloid leukemia by enhancing the expression of RAB10 via binding to miR-622.环状RNA_KCNQ5通过与微小RNA-622结合增强RAB10的表达,从而参与儿童急性髓系白血病的进展。
Hematology. 2022 Dec;27(1):431-440. doi: 10.1080/16078454.2022.2056983.
7
Therapeutic Strategies Targeting Urokinase and Its Receptor in Cancer.癌症中针对尿激酶及其受体的治疗策略
Cancers (Basel). 2022 Jan 19;14(3):498. doi: 10.3390/cancers14030498.
8
Emerging role of let-7 family in the pathogenesis of hematological malignancies.Let-7 家族在血液系统恶性肿瘤发病机制中的新作用。
Biomed Pharmacother. 2021 Dec;144:112334. doi: 10.1016/j.biopha.2021.112334. Epub 2021 Oct 13.
9
The Roles of the Let-7 Family of MicroRNAs in the Regulation of Cancer Stemness.Let-7 家族 microRNAs 在调控癌症干性中的作用。
Cells. 2021 Sep 14;10(9):2415. doi: 10.3390/cells10092415.
10
The Urokinase Receptor: A Multifunctional Receptor in Cancer Cell Biology. Therapeutic Implications.尿激酶型纤溶酶原激活物受体:癌细胞生物学中的多功能受体。治疗意义。
Int J Mol Sci. 2021 Apr 16;22(8):4111. doi: 10.3390/ijms22084111.